Pyridazine, 3-ethenyl-6-methoxy- | 1408335-28-3

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: Pyridazine, 3-ethenyl-6-methoxy-
• 英文别名: 3-ethenyl-6-methoxypyridazine
• CAS: 1408335-28-3
• 化学式: C₇H₈N₂O
• 分子量: 136.153
• InChiKey: LUUSQJKRZNNOPN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  10
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  35
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• Isoxazolines as Therapeutic Agents
  申请人：Calderwood David J.

  公开号：US20130023526A1

  公开（公告）日：2013-01-24

  The present invention provides compound of Formula (I) biologically active metabolites, pro-drugs, isomers, stereoisomers, solvates, hydrates and pharmaceutically acceptable salts thereof wherein the variables are defined herein. The compounds of the invention are useful for treating immunological conditions.

  本发明提供了化合物Formula（I）的生物活性代谢产物、前药、异构体、立体异构体、溶剂合物、水合物和其药学上可接受的盐，其中变量在此处定义。本发明的化合物对治疗免疫状况有用。
• ISOXAZOLINES AS THERAPEUTIC AGENTS
  申请人：ABBVIE INC.

  公开号：US20150297596A1

  公开（公告）日：2015-10-22

  The present invention provides compound of Formula (I) biologically active metabolites, pro-drugs, isomers, stereoisomers, solvates, hydrates and pharmaceutically acceptable salts thereof wherein the variables are defined herein. The compounds of the invention are useful for treating immunological conditions.

  本发明提供了化合物式（I）的生物活性代谢物、前药、异构体、立体异构体、溶剂化物、水合物及其药学上可接受的盐，其中变量如本文所定义。本发明化合物用于治疗免疫疾病。
• NITRIFICATION INHIBITORS
  申请人：Lincoln University

  公开号：US20220153655A1

  公开（公告）日：2022-05-19

  Nitrification inhibitors and uses of same to prevent nitrate leaching or nitrous oxide emissions as well as increase pasture or crop production. The nitrification inhibitors and formulations including same may be used for direct or indirect application to soil or pasture.

  硝化抑制剂及其用途，可防止硝酸盐淋失或氧化亚氮排放，并增加牧草或作物产量。硝化抑制剂及其配方可用于直接或间接施用于土壤或牧草。
• US9029409B2
  申请人：——

  公开号：US9029409B2

  公开（公告）日：2015-05-12
• [EN] ISOXAZOLINES AS THERAPEUTIC AGENTS<br/>[FR] ISOXAZOLINES UTILISÉES EN TANT QU'AGENTS THÉRAPEUTIQUES
  申请人：ABBOTT LAB

  公开号：WO2012151158A1

  公开（公告）日：2012-11-08

  The present invention provides compound of Formula (1) biologically active metabolites, pro-drugs, isomers, stereoisomers, solvates, hydrates and pharmaceutically acceptable salts thereof wherein the variables are defined herein. The compounds of the invention are useful for treating immunological conditions. X is an optionally substituted ring system which is aromatic, partly aromatic or non-aromatic having one or more fused ring systems.